As expected, the BRD4‐downstream target MYC was expressed in primary CML cells and in all CML cell lines tested, with higher MYC mRNA levels found in KU812 cells than in K562 cells. The gene discussed is BRD4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.